Engaged in large-scale contract manufacturing for cosmetics and drug majors, Officiana Farmaceutica Italiana (OFI) is awaiting a nod from the Foreign Investment Promotion Board (FIPB) to start single-brand retail business in India, along with local joint venture partner San Pellegrino Cosmetics. The Italian company would invest 51 per cent in the joint venture.
OFI is considering a foray into India, as a test case for international expansion. The company would set up stores for its brand Bottega di LungaVita here and plan expansion in other countries depending on the success here. So far, it has three flagship stores in Italy. About 70 per cent of its business, estimated at about ^250 million (about Rs 1,775 crore) is focused on contract manufacturing for brands such as Revlon, Merck and Sanofi in key markets, according to OFI president and chief executive Alberto Donati.
The company is likely to set up five standalone stores and at least 200 counters across outlets in India through the next five years. It would begin with an initial investment of ^2 million (about Rs 14.2 crore) through 18 months and step up funding subsequently, Donati said. Apart from metros and other major cities, the company is also trying to tap markets such as India's Northeast.
OFI is also exploring the option of setting up a manufacturing and packaging base in India. It is already scouting for the right locations for contract manufacturing in the country. Though the company does not have to necessarily source from India, it may consider substantial sourcing of natural products for its anti-ageing skin range, as well as other wellness products.
Currently, OFI operates across three segments-cosmetics, medical devices and food supplements. The company has submitted applications to various authorities, including the Ministry of Health and Food Safety and the Food Safety and Standards Authority of India.
Donati said the company was targeting neither the niche, nor the lowest strata; it would price its products at Rs 600-3,000.
The cosmetics market in India is estimated at Rs 26,400 crore, while the market for anti-ageing stands at Rs 1,400 crore, growing 30 per cent a year.
According to reports, other major Italian brands, albeit in the luxury fashion segment, lining up for an India foray include Alberta Ferretti, Pollini and Gattinoni, among others, according to reports.
THE BELLEZZA AFFAIR
* Italian cosmetics and wellness company, Officiana Farmaceutica Italiana (OFI), awaiting FIPB nod to start single-brand retail business in India with local joint venture partner San Pellegrino Cosmetics
* Entry with initial investment of ^ 2 million (around Rs 14.2 crore) over a period of 18 months
* Has three flagship stores in Italy. 70% of its business, estimated at around ^250 million (around Rs 1,775 crore).
* Mainly does contract manufacturing for brands such as Revlon, Merck, Sanofi, etc.
* Likely to set up 5 standalone stores and at least 200 counters across outlets in India over the next five years
* Apart from metros and other big cities, the company is trying to tap markets such as the north-east in India
Rs 26,400 cr
Estimated value of cosmetics market in India
Rs 1,400 cr
Market of anti-ageing products
30%
Y-O-Y growth of anti-ageing products
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)